Laura Baglietto mainly focuses on Breast cancer, Internal medicine, Oncology, Genome-wide association study and Cancer. Her Breast cancer study combines topics from a wide range of disciplines, such as Odds ratio, Body mass index, Case-control study and Genetic predisposition. Her research integrates issues of Endocrinology, Surgery and Pathology in her study of Internal medicine.
Her Oncology research incorporates elements of Bioinformatics, Prostate cancer, Hazard ratio, Triple-negative breast cancer and Estrogen. Her study focuses on the intersection of Genome-wide association study and fields such as TOX3 with connections in the field of TCF7L2, Triple Negative Breast Neoplasms and MAP3K1. Laura Baglietto combines subjects such as Germline mutation and Gene mutation with her study of Cancer.
Internal medicine, Breast cancer, Oncology, Prospective cohort study and Case-control study are her primary areas of study. In Internal medicine, Laura Baglietto works on issues like Endocrinology, which are connected to Physiology. Her studies deal with areas such as Genome-wide association study, Single-nucleotide polymorphism and Gynecology as well as Breast cancer.
The Genome-wide association study study combines topics in areas such as Genotyping, Allele and Genetic association. Her Oncology study combines topics in areas such as Methylation, Genetic predisposition, Bioinformatics, Pathology and Ovarian cancer. Laura Baglietto works mostly in the field of Prospective cohort study, limiting it down to topics relating to Body mass index and, in certain cases, Mammography.
Her primary areas of investigation include Internal medicine, Breast cancer, Cohort study, Oncology and Prospective cohort study. Her research in Internal medicine is mostly concerned with Case-control study. Her Breast cancer study is associated with Cancer.
Her research in Cohort study intersects with topics in Gerontology, Cohort, Disease, Hazard ratio and Confounding. Within one scientific family, Laura Baglietto focuses on topics pertaining to CpG site under Oncology, and may sometimes address concerns connected to Lung cancer, Prostate, Nested case-control study and Prostate cancer. Her Prospective cohort study course of study focuses on Obesity and Cause of death.
Laura Baglietto mostly deals with Prospective cohort study, Cohort study, Cancer, Breast cancer and Internal medicine. Her Prospective cohort study research is multidisciplinary, relying on both Red meat, Food science and Obesity. Her Cohort study research is multidisciplinary, incorporating elements of Body mass index, Proportional hazards model, Cohort and Hazard ratio.
Her work carried out in the field of Breast cancer brings together such families of science as Young adult, Genome-wide association study and Obstetrics. Her Internal medicine research is multidisciplinary, incorporating perspectives in Immunology and Oncology. Her study in Oncology is interdisciplinary in nature, drawing from both Epidemiology of cancer, Methylation, Epigenetics and Quartile.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies
Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks.
PLOS Medicine (2010)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev.
American Journal of Human Genetics (2015)
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch.
Journal of the National Cancer Institute (2011)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
Leigha Senter;Mark Clendenning;Kaisa Sotamaa;Heather Hampel.
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Shahana Ahmed;Gilles Thomas;Maya Ghoussaini;Catherine S. Healey.
Nature Genetics (2009)
Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics
Montserrat Garcia-Closas;Per Hall;Heli Nevanlinna;Karen Pooley.
PLOS Genetics (2008)
Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Montserrat Garcia-Closas;Fergus J. Couch;Sara Lindstrom;Kyriaki Michailidou.
Nature Genetics (2013)
Circulating sex hormones and breast cancer risk factors in postmenopausal women: Reanalysis of 13 studies
T J Key;P N Appleby;G K Reeves;A W Roddam;A W Roddam.
British Journal of Cancer (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: